Showing 4611-4620 of 10637 results for "".
Institute for Healthcare Improvement: Past and Present Goals
https://reachmd.com/programs/clinicians-roundtable/institute-for-healthcare-improvement-past-and-present-goals/2111/In the first part of this interview, Dr. John Whittington talks with host Dr. Mark Nolan Hill about the history and initiatives of the Institute for Healthcare Improvement. In the second part of this segment he talks about Triple Aim: a healthcare challenge to improve the health of a defined populatWomen's Role in the Control of TB in India
https://reachmd.com/programs/clinicians-roundtable/womens-role-in-the-control-of-tb-in-india/1391/Dr. Maurice Pickard speaks with Dr. Shelly Batra, gynecologist and Medical Director for Operation Asha based in New Delhi, who expanded her vision for better women's health by confronting a well established taboo in her culture. Women are fearful about seeking medical care for tuberculosis, as thisUncovering the Prevalence of Type 1 Diabetes in Older Adults
https://reachmd.com/programs/diabetes-discourse/uncovering-the-prevalence-of-type-1-diabetes-in-older-adults/17888/Treating older adults with type 1 diabetes requires proactive assessment and management strategies. Here are ways to improve outcomes in a population faced with increased complications.Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
https://reachmd.com/programs/cme/optimizing-barostim-outcomes-practical-approaches-to-patient-selection-and-monitoring/29819/Explore best practices for talking to patients about their QoL and successfully identifying appropriate candidates for treatment with Barostim.The Impact of Psoriasis by the Numbers
https://reachmd.com/programs/dermconsult/the-impact-of-psoriasis-by-the-numbers/36451/The Silent Struggle: Understanding ADHD's Impact on Girls and Women
https://reachmd.com/programs/neurofrontiers/the-silent-struggle-understanding-adhds-impact-on-girls-and-women/24154/ADHD impacts girls and women differently than boys and men. Here’s how.Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
https://reachmd.com/programs/project-oncology/retifanlimab-pod1um-303-subgroups-anal-canal-scc/54279/Subgroup analyses from the phase 3 POD1UM-303/INTERAACT2 trial offer important insights into the use of retifanlimab with carboplatin and paclitaxel for advanced squamous cell carcinoma of the anal canal. Joining Dr. Charles Turck to break down the data is Dr. Marwan Fakih, Professor in the DepartmeDoctor as Patient Advocate: Top Tools to Empower Your Patients
https://reachmd.com/programs/heart-matters/doctor-as-patient-advocate-top-tools-to-empower-your-patients/5591/Recommendations and ratings are a dime a dozen for patients looking for more information about a physician or procedure online, but finding quality, consumer-friendly information that's also reliable can be more of a challenge. What tools can physicians recommend to patients for understanding the imADAPT AF-DES: Antithrombotic Strategies Beyond 12 Months for Patients With AF Treated With Drug-Eluting-Stents
https://reachmd.com/clinical-practice/cardiology/adapt-af-des-antithrombotic-strategies-beyond-12-months-for-patients-with-af-treated-with-drug-eluting-stents/48694/Will ADAPT AF-DES findings affect your practice? Tune in for antithrombotic management strategies for patients with drug-eluting stents in the setting of AF.A Physician’s Perspective on Finding a Balance with Locum Tenens
https://reachmd.com/programs/locumtenens/a-physicians-perspective-on-finding-a-balance-with-locum-tenens/12525/How does someone decide that Locum Tenens is right for them?